SCHEMBL17640671

SCHEMBL17640671

C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A5 Q9Y345 1/20 0.48
▸ EPHX2 P34913 1/20 0.44
▸ F2 P00734 3/20 0.40
▸ PRSS1 P07477 3/20 0.40
▸ PRSS2 P07478 3/20 0.40
▸ PRSS3 P35030 3/20 0.40
▸ QPCT Q16769 1/20 0.39
▸ QPCTL Q9NXS2 1/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ FAAH O00519 2/20 0.39
▸ CNR1 P21554 2/20 0.39
▸ CNR2 P34972 2/20 0.39
▸ ITGB2 P05107 1/20 0.39
▸ ICAM1 P05362 1/20 0.39
▸ ITGAL P20701 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16273559 0.92 SLC6A5 (0.57) SLC6A5EPHX2F2PRSS1PRSS2
SCHEMBL16870591 0.85 SLC6A5 (0.59) SLC6A5EPHX2F2PRSS1PRSS2
SCHEMBL17636914 0.82 SLC6A5 (0.59) SLC6A5EPHX2FAAHCNR1CNR2
SCHEMBL18329855 0.78 SLC6A5 (0.54) SLC6A5EPHX2F2PRSS1PRSS2
SCHEMBL16364168 0.77 CYP3A4 (0.54) SLC6A5EPHX2CYP3A4CYP2C19CYP2D6
SCHEMBL27675779 0.76 EPHX2 (0.60) SLC6A5EPHX2F2PRSS1PRSS2
SCHEMBL3057446 0.76 EPHX2 (0.60) SLC6A5EPHX2F2PRSS1PRSS2
SCHEMBL29615190 0.76 EPHX2 (0.60) SLC6A5EPHX2F2PRSS1PRSS2
SCHEMBL16273558 0.75 SLC6A5 (0.69) SLC6A5EPHX2CYP3A4CYP2C19FAAH
SCHEMBL23787478 0.74 QPCT (0.53) SLC6A5EPHX2F2PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016203337-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER MOHAN M ALAPATI (IN) 2016-12-22 — — WO disclosed
WO-2016046672-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DIABETES MOHAN M ALAPATI (IN) 2016-03-31 — — WO disclosed
WO-2016046675-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES MOHAN M ALAPATI (IN) 2016-03-31 — — WO disclosed
Send feedback